162 related articles for article (PubMed ID: 25920510)
21. Prognostic value of bone marrow involvement by clonal immunoglobulin gene rearrangements in follicular lymphoma.
Berget E; Helgeland L; Liseth K; Løkeland T; Molven A; Vintermyr OK
J Clin Pathol; 2014 Dec; 67(12):1072-7. PubMed ID: 25233852
[TBL] [Abstract][Full Text] [Related]
22. Assessment of bone marrow involvement in non-Hodgkin's lymphomas: comparison between histology and flow cytometry.
Merli M; Arcaini L; Boveri E; Rattotti S; Picone C; Passamonti F; Tenore A; Sozzani L; Lucioni M; Varettoni M; Rizzi S; Morello L; Ferretti V; Pascutto C; Paulli M; Lazzarino M
Eur J Haematol; 2010 Nov; 85(5):405-15. PubMed ID: 20662897
[TBL] [Abstract][Full Text] [Related]
23. Bone marrow biopsy in non-Hodgkin lymphoma: a morphological study.
Kumar S; Rau AR; Naik R; Kini H; Mathai AM; Pai MR; Khadilkar UN
Indian J Pathol Microbiol; 2009; 52(3):332-8. PubMed ID: 19679954
[TBL] [Abstract][Full Text] [Related]
24. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
[TBL] [Abstract][Full Text] [Related]
25. Prognostic impact of extranodal involvement in diffuse large B-cell lymphoma in the rituximab era.
Takahashi H; Tomita N; Yokoyama M; Tsunoda S; Yano T; Murayama K; Hashimoto C; Tamura K; Sato K; Ishigatsubo Y
Cancer; 2012 Sep; 118(17):4166-72. PubMed ID: 22213346
[TBL] [Abstract][Full Text] [Related]
26. Primary bone lymphoma: a new and detailed characterization of 28 patients in a single-institution study.
Maruyama D; Watanabe T; Beppu Y; Kobayashi Y; Kim SW; Tanimoto K; Makimoto A; Kagami Y; Terauchi T; Matsuno Y; Tobinai K
Jpn J Clin Oncol; 2007 Mar; 37(3):216-23. PubMed ID: 17472971
[TBL] [Abstract][Full Text] [Related]
27. Routine conventional karyotyping of lymphoma staging bone marrow samples does not contribute clinically relevant information.
Nardi V; Pulluqi O; Abramson JS; Dal Cin P; Hasserjian RP
Am J Hematol; 2015 Jun; 90(6):529-33. PubMed ID: 25776302
[TBL] [Abstract][Full Text] [Related]
28. Clinical utility of bone marrow flow cytometry in B-cell non-Hodgkin lymphomas (B-NHL).
Perea G; Altés A; Bellido M; Aventín A; Bordes R; Ayats R; Remacha AF; Espinosa I; Briones J; Sierra J; Nomdedéu JF
Histopathology; 2004 Sep; 45(3):268-74. PubMed ID: 15330805
[TBL] [Abstract][Full Text] [Related]
29. Oncologic outcomes of primary lymphoma of bone in adults.
Lewis VO; Primus G; Anastasi J; Doherty D; Montag AG; Peabody TD; Simon MA
Clin Orthop Relat Res; 2003 Oct; (415):90-7. PubMed ID: 14612634
[TBL] [Abstract][Full Text] [Related]
30. The prognostic impact of bone marrow involvement in patients with diffuse large cell lymphoma varies according to the degree of infiltration and presence of discordant marrow involvement.
Campbell J; Seymour JF; Matthews J; Wolf M; Stone J; Juneja S
Eur J Haematol; 2006 Jun; 76(6):473-80. PubMed ID: 16529599
[TBL] [Abstract][Full Text] [Related]
31. [Incidence and histologic patterns of bone marrow involvement of malignant lymphoma based on the World Health Organization classification: a single institution study].
Jeong SY; Chang YH; Lee JK; Hong YJ; Hong SI; Lee SS
Korean J Lab Med; 2007 Dec; 27(6):383-7. PubMed ID: 18160826
[TBL] [Abstract][Full Text] [Related]
32. [A multidisciplinary study of the staging of malignant lymphoma].
Tono H; Sawada U; Amaki I; Takashima H; Shimada Y; Sanuki E; Sato K; Kumagai Y; Kamata R; Kurosu Y
Rinsho Ketsueki; 1986 Mar; 27(3):327-37. PubMed ID: 3735685
[No Abstract] [Full Text] [Related]
33. [Expression of Cdc7 and mcm2 as a marker for proliferation and prognosis in diffuse large B cell lymphoma].
Hou Y; Wang HQ; Fu K; Zhang HL; Qian ZZ; Qiu LH; Li W; Zhou SY; Li LF; Hao XS
Zhonghua Zhong Liu Za Zhi; 2011 Dec; 33(12):911-5. PubMed ID: 22340100
[TBL] [Abstract][Full Text] [Related]
34. Bone marrow staging of patients with non-Hodgkin lymphoma by flow cytometry: correlation with morphology.
Duggan PR; Easton D; Luider J; Auer IA
Cancer; 2000 Feb; 88(4):894-9. PubMed ID: 10679660
[TBL] [Abstract][Full Text] [Related]
35. Presence of a high-grade component in gastric mucosa-associated lymphoid tissue (MALT) lymphoma is not associated with an adverse prognosis.
Ang MK; Hee SW; Quek R; Yap SP; Loong S; Tan L; Tao M; Lim ST
Ann Hematol; 2009 May; 88(5):417-24. PubMed ID: 18777110
[TBL] [Abstract][Full Text] [Related]
36. A single unit lymphoma experience: outcome in a Cape Town academic centre.
Wood L; Robinson R; Gavine L; Juritz J; Jacobs P
Transfus Apher Sci; 2007 Aug; 37(1):93-102. PubMed ID: 17931976
[TBL] [Abstract][Full Text] [Related]
37. Bone marrow involvement in lymphoma: the importance of marrow magnetic resonance imaging.
Takagi S; Tsunoda S; Tanaka O
Leuk Lymphoma; 1998 May; 29(5-6):515-22. PubMed ID: 9643565
[TBL] [Abstract][Full Text] [Related]
38. [Bone-marrow involvement in non-Hodgkin lymphoma (author's transl)].
Bueno Aribayos J; Hernández-Nieto L; Aranalde JM; Feliu E; Grañena A; Montserrat E; Nomdedeu B; Rozmán C
Sangre (Barc); 1978; 23(2):129-37. PubMed ID: 653548
[No Abstract] [Full Text] [Related]
39. Investigation of bone marrow involvement in malignant lymphoma using fluorescence in situ hybridization: possible utility in the detection of micrometastasis.
Huh HJ; Min HC; Cho HI; Chae SL; Lee DS
Cancer Genet Cytogenet; 2008 Oct; 186(1):1-5. PubMed ID: 18786435
[TBL] [Abstract][Full Text] [Related]
40. Risk factors for poor treatment outcome and central nervous system relapse in diffuse large B-cell lymphoma with bone marrow involvement.
Lee KW; Yi J; Choi IS; Kim JH; Bang SM; Kim DW; Im SA; Kim TY; Yoon SS; Lee JS; Bang YJ; Park S; Kim BK; Cho HI; Heo DS
Ann Hematol; 2009 Sep; 88(9):829-38. PubMed ID: 19172274
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
